January 5, 2023
3 min read
Bespoke telephony developer and operator Callagenix Ltd has been acquired by leading technology services provider Chess, as part of a deal to further strengthen the firms offering in the space. The Berkshire based business, established in 1999, uses a self-developed billing and operational platform to provide its services, principally focused on inbound telephony and associated services. Founded by brothers Mark and Tony Jenkins alongside a partner, now retired, the semi-automated platform attracts a wide breadth of variety across its customer base, allowing access to tailored services including call recording, international services and virtualised call centre operations.
“The integration of Callagenix into Chess, will not only allow our customers to continue to benefit from the high levels of service to which they have become accustomed, but also provide the added flexibility of them being able to easily add additional services and further streamline their own digital transformation,” Mark Jenkins, co-founder of Callagenix explained. “We are delighted the services we have constantly evolved over the past 20 years in building and maintaining Callagenix have been recognised by Chess, and that our longstanding customer-base will continue to be fully supported under the new ownership structure.”
David Pollock, Chess Founder and Executive Chairman, commented:
“The acquisition of Callagenix enhances our hybrid telephony proposition. Hybrid working is here to stay. We adopted the model successfully at the start of the pandemic. We help our customers do the same, to make it easy to work securely anywhere, anytime.”
The deal has been managed with specialist corporate finance boutique Evolution Capital providing advisory support to the vendor, throughout both pre and post-transaction work, including full due diligence .
“We are delighted to have worked with Mark and Tony throughout the process, helping them achieve their aspirations for both the business and their loyal customer base,” explains Sam Godfrey, Senior Transaction Advisor with Evolution Capital. “Across all potential acquirers through the process, we felt that Chess best understood the strength of Callagenix and the benefits it could bring to their own customers moving forwards. We are very pleased to have achieved another outstanding outcome for our clients and wish Mark and Tony every continued success with their future ventures.”
Read more about the transaction here: https://www.evolutioncapital.com/case-studies/callagenix-2